Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BrainStorm, PRC sign MoU for clinical trial management in US
Currently conducting a Phase IIa dose-escalating trial with 12 ALS patients at the Hadassah Medical Center in Jerusalem, Israel, the company is scheduled to begin a Phase II
Currently conducting a Phase IIa dose-escalating trial with 12 ALS patients at the Hadassah Medical Center in Jerusalem, Israel, the company is scheduled to begin a Phase II
People familiar with the matter were quoted by media sources as saying that Sanofi and GSK have placed in non-binding bids, whereas Novartis has entered into a non-disclosure
Under the supervision of the Korea Food & Drug Administration (KFDA), Cha will carry out and fund multiple clinical trials in South Korea to treat CLI and IC
Lake Chemicals managing director Manoj Palrecha was quoted by Pharmabiz as saying that the company already has the EU GMP certification and is currently engaged in talks with
Roche Diagnostics chief medical officer Dr Alan Wright said the demand for HPV co-testing has the potential to increase significantly after the new clinical guidelines for cervical cancer
As part of the agreement, SciClone receives license and exclusive rights to promote, market, distribute and sell ProFlow in China, Hong Kong and Macau. SciClone chief executive officer
Amitiza’s launch has triggered a $10m milestone payment from Takeda Pharmaceutical as part of the collaboration and license agreement between both the companies signed in 2004 for US
Initiated in 2009, the concept has been designed to offer an alternative to global CROs and to reduce R&D costs, while leveraging local expertise and quality. Enabling select
Pfizer will continue providing full funding for the costs of research to discover and develop novel small molecule RORgamma modulators. Target for the treatment of autoimmune diseases, RORgamma
Merck Serono Global Research and Early Development head Bernhard Kirschbaum said the platform recognizes the complexity of cancer, which requires diverse approaches to enable alternative therapeutic interventions. "In